NCT03885167View on ClinicalTrials.gov

Identification of Biomarkers in Spinocerebellar Ataxia 3

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

February 21, 2019

Primary Completion Date

January 4, 2023

Study Completion Date

January 4, 2023

Conditions
Spinocerebellar Ataxia Type 3
Interventions
OTHER

Specimen Collection

No interventions take place as part of study participation- only specimen collection occurs for both cohorts.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Michigan

OTHER

NCT03885167 - Identification of Biomarkers in Spinocerebellar Ataxia 3 | Biotech Hunter | Biotech Hunter